Everest Clinical Research and the Friedreich’s Ataxia Research Alliance (FARA) Announce Biostatistics Partnership to Advance Research in Friedreich’s Ataxia
FARA News
News|Feb 24 2026
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026
Industry News
Blog|Feb 23 2026
Meet the Community: Theresa Kornfell
Community
News|Feb 19 2026
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results